Pandemic fears hatch new methods in flu vaccine industry

Article Abstract:

Biotechnolgy companies are keen to develop faster ways to make flu vaccines, as there are warnings of an impending worldwide influenza epidemic. However, Klaus Stohr, head of the World Health Organization's Global Influenza Program states that using the current vaccine manufacturing methods, it would take six months to create a clinically tested vaccine.

Manufacturing processes, Management dynamics, Management, Biotechnology industry, Biotechnology industries, Influenza vaccines, Beliefs, opinions and attitudes, Company process management, Production processes, Influenza, Control, Company business management, Stohr, Klaus

---

Chiron flu flap suggests vaccine industry needs shot in the arm

Article Abstract:

The surprise announcement that Chiron would not be able to deliver half the US flu vaccine supply has prompted scientists to call for changes to vaccine development. The severe shortage suggests the government is not prepared to deal with an infectious pandemic and that the government has to develop long-term solutions for recurring vaccine problems.

Production management, HEALTH SERVICES, All Other Miscellaneous Ambulatory Health Care Services, Vaccination & Immunization, Prevention, Biological products industry, Vaccination, Chiron Corp., CHIR, Epidemics

---

Similar abstracts:

• Abstracts: Mental health research emerges from hurricane ruin. Scientists stumped by dual push for open access, secrecy. Race-based heart drug might stall search for better markers
• Abstracts: Senescence comes of age. Roots and stems: Stem cells in cancer. Telomeres and telomerase: The path from maize, tetrahymena and yeast to human cancer and aging
• Abstracts: Antibiotic treatment of children with sore throat. Gaps in vaccine financing for underinsured children in the U.S
• Abstracts: Fears over Tamiflu side-effects. What caused the flu vaccine crisis? Lack of diagnostic evidence puts chlamydia screening to test
• Abstracts: Patients turned away in vaccine shortage. Identifying and managing acute coronary syndrome. Betamethasone sodium phosphate

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.